Assay To Measure Pct To Aid In The Risk Assessment Of Critically Ill Patients On Their First Day Of Icu Admission

FDA classification

FDA Class 2 ·Assay To Measure Pct To Aid In The Risk Assessment Of Critically Ill Patients On Their First Day Of Icu Admission

Antibodies, Outer-Membrane Proteins

FDA classification

FDA Class 2 ·Antibodies, Outer-Membrane Proteins

Galectin-3 In Vitro Diagnostic Assay

FDA classification

FDA Class 2 ·Galectin-3 In Vitro Diagnostic Assay

Sirolimus Test System

FDA classification

FDA Class 2 ·Sirolimus Test System

Deformability Cytometry For Sepsis Risk Assessment

FDA classification

FDA Class 2 ·Deformability Cytometry For Sepsis Risk Assessment

ß-Galactocerebrosidase (Galc) Newborn Screening Test System

FDA classification

FDA Class 2 ·ß-Galactocerebrosidase (Galc) Newborn Screening Test System

Influenza A Virus Subtype Differentiation Nucleic Acid Assay

FDA classification

FDA Class 2 ·Influenza A Virus Subtype Differentiation Nucleic Acid Assay

System, Cystic Fibrosis Transmembrane Conductance Regulator Gene, Mutations & Variants Panel Sequencing Detection

FDA classification

FDA Class 2 ·System, Cystic Fibrosis Transmembrane Conductance Regulator Gene, Mutations & Variants Panel Sequencing Detection

Automated Digital Image Manual Interpretation Microscope

FDA classification

FDA Class 2 ·Automated Digital Image Manual Interpretation Microscope

Novel Influenza A Virus, A/H5 Ns1 Protein

FDA classification

FDA Class 2 ·Novel Influenza A Virus, A/H5 Ns1 Protein

Acid-Sphingomyelinase (Asm) Newborn Screening Test System

FDA classification

FDA Class 2 ·Acid-Sphingomyelinase (Asm) Newborn Screening Test System

Orthopedic Infection Microbial Multiplex Nucleic Acid Detection System

FDA classification

FDA Class 2 ·Orthopedic Infection Microbial Multiplex Nucleic Acid Detection System

Infliximab Test System

FDA classification

FDA Class 2 ·Infliximab Test System

Gabapentin Assay

FDA classification

FDA Class 2 ·Gabapentin Assay

Test, Factor Ii G20210a Mutations, Genomic Dna Pcr

FDA classification

FDA Class 2 ·Test, Factor Ii G20210a Mutations, Genomic Dna Pcr

Test, Factor V Leiden Mutations, Genomic Dna Pcr

FDA classification

FDA Class 2 ·Test, Factor V Leiden Mutations, Genomic Dna Pcr

Chromogranin A

FDA classification

FDA Class 2 ·Chromogranin A

Antibodies, Anti-Cyclic Citrullinated Peptide (Ccp)

FDA classification

FDA Class 2 ·Antibodies, Anti-Cyclic Citrullinated Peptide (Ccp)

Autoantibodies, Nuclear Body Protein, Sp100

FDA classification

FDA Class 2 ·Autoantibodies, Nuclear Body Protein, Sp100

Autoantibodies, Nuclear Pore Glycoprotein Gp210

FDA classification

FDA Class 2 ·Autoantibodies, Nuclear Pore Glycoprotein Gp210